Tau and 14-3-3 of genetic and sporadic Creutzfeldt-Jakob disease patients in Israel.
One of the largest clusters of genetic Creutzfeldt-Jakob disease (gCJD) is found among Jews of Libyan origin in Israel and is linked to the E200K mutation in PRNP (gCJDE200K). The aim of this study was to compare the levels of cerebrospinal fluid (CSF) biomarkers, Tau and 14-3-3 proteins, between gCJDE200K patients, sporadic CJD (sCJD) patients and non-CJD controls in Israel between the years 1996-2006. The levels of Tau and 14-3-3 proteins in CSF were measured by ELISA and immunoblotting, respectively. CSF Tau levels were similar in gCJDE200K and sCJD, both were significantly higher than in controls [1,107 ± 470 pg/ml [33/46 (72%)] of the cases >1,000 pg/ml, 1,280 ± 580 pg/ml [25/30 (83.3%)], and 354 ± 338 pg/ml [17/243 (6.9%)], respectively, p < 0.001]. 14-3-3 was detected in CSF of 41/53 (77%) of each gCJDE200K and sCJD patients tested, but only in 70/417 (16.8%) of controls (p < 0.001). An inverse correlation was found between disease duration and Tau levels in both gCJDE200K and sCJD (r = -0.464 and r = -0.284). No difference was found in Tau or 14-3-3 between the various codon 129 genotypes. We conclude that CSF biomarkers, Tau and 14-3-3, may be used in the diagnosis in both patients' populations, presenting a similar sensitivity yet Tau assay having higher specificity.
Meiner
Zeev
Z
Departments of Neurology, Hadassah University Hospital, Jerusalem, Israel. meiner@hadassah.org.il
Kahana
Esther
E
Baitcher
Fanny
F
Korczyn
Amos D
AD
Chapman
Joab
J
Cohen
Oren S
OS
Milo
Ron
R
Aharon-Perez
Judith
J
Abramsky
Oded
O
Gabizon
Ruth
R
Rosenmann
Hanna
H
D048948:14-3-3 Proteins / Q000134:cerebrospinal fluid* / Q000235:genetics; D000368:Aged; D015415:Biomarkers / Q000134:cerebrospinal fluid; D007562:Creutzfeldt-Jakob Syndrome / Q000134:cerebrospinal fluid* / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D015151:Immunoblotting; D007557:Israel; D008297:Male; D008875:Middle Aged; D009154:Mutation; D000072002:Prion Proteins; D011328:Prions / Q000235:genetics; D012680:Sensitivity and Specificity; D016875:tau Proteins / Q000134:cerebrospinal fluid* / Q000235:genetics
D048948:14-3-3 Proteins; D015415:Biomarkers; C512656:PRNP protein, human; D000072002:Prion Proteins; D011328:Prions; D016875:tau Proteins
Cell Mol Neurobiol. 2006 Feb;26(1):45-52
16633900
Dement Geriatr Cogn Disord. 2007;24(3):207-12
17690553
Hum Genet. 2005 Nov;118(2):166-74
16187142
J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):744-8
11385008
Arch Neurol. 2003 Jun;60(6):813-6
12810484
AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1551-62
15956529
Lancet. 1999 May 15;353(9165):1673-4
10335789
Neurology. 1991 Sep;41(9):1390-2
1891087
Eur J Neurol. 2007 Feb;14(2):121-4
17250717
Neurology. 2002 Jan 22;58(2):192-7
11805244
Eur J Epidemiol. 1991 Sep;7(5):490-3
1761106
Neurosci Lett. 1997 Apr 11;225(3):210-2
9147407
Neurology. 1991 Sep;41(9):1385-9
1891086
N Engl J Med. 1991 Apr 18;324(16):1091-7
2008182
J Neurol. 2009 Oct;256(10):1620-8
19444528
Science. 1974 Jan 11;183(4120):90-1
4587265
Neurology. 2004 Aug 10;63(3):450-6
15314808
Neuroepidemiology. 1991;10(5-6):228-31
1798423
Lancet. 1990 Sep 8;336(8715):637-8
1975415
Acta Virol. 2002;46(1):31-9
12197632
N Engl J Med. 2001 May 17;344(20):1516-26
11357156
Am J Hum Genet. 1993 Oct;53(4):828-35
8105682
Neurology. 2004 Aug 10;63(3):436-42
15304573
Br Med Bull. 1993 Oct;49(4):960-70
8137137
J Neurol. 2003 May;250(5):629-30
12814120
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1210-4
12933920
Medicine (Baltimore). 1997 Jul;76(4):227-37
9279329
Neurobiol Aging. 2009 May;30(5):672-81
17920160
Neurology. 2006 Aug 22;67(4):637-43
16924018
Ann Neurol. 1998 Jan;43(1):32-40
9450766
Neurosci Lett. 2002 May 10;324(1):57-60
11983294
Neurobiol Aging. 2006 Jan;27(1):10-5
16298235
Dement Geriatr Cogn Disord. 2005;19(5-6):376-82
15802913
Eur J Hum Genet. 2006 Mar;14(3):273-81
16391566
N Engl J Med. 1996 Sep 26;335(13):924-30
8782499
J Neurol. 2007 Jul;254(7):901-6
17385081
Neurology. 1997 Aug;49(2):593-5
9270603